These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3937805)

  • 1. [The anti-inflammatory effect of auranofin].
    Hiroi J; Ohara K; Fujitsu T; Hirai O; Satoh S; Ochi T; Senoh H; Mori J; Kikuchi H
    Nihon Yakurigaku Zasshi; 1985 Dec; 86(6):441-55. PubMed ID: 3937805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gold salts, D-penicillamine and benoxaprofen on type II collagen-induced arthritis in rats.
    Lewis AJ; Carlson RP; Chang J; DeLustro F
    Agents Actions; 1984 Jun; 14(5-6):707-14. PubMed ID: 6433677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic actions and pharmacokinetic studies of auranofin.
    Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
    Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of natural killer cells in patients with rheumatoid arthritis: I. The effect of drugs used in vivo.
    Russell AS; Miller C
    Clin Exp Rheumatol; 1984; 2(3):227-9. PubMed ID: 6442225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological profile of auranofin, an orally active gold compound.
    Walz DT; DiMartino MJ; Griswold DE
    Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 8. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162): effects on cell-mediated immunity.
    Walz DT; Griswold DE
    Inflammation; 1978 Jun; 3(2):117-28. PubMed ID: 104929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
    Furst DE
    Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.
    Connolly KM; Stecher VJ; Danis E; Pruden DJ; LaBrie T
    Agents Actions; 1988 Aug; 25(1-2):94-105. PubMed ID: 3142230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of slow-acting antirheumatic drugs on blast formation of normal lymphocytes].
    Hamai T; Negishi M; Takahashi T
    Ryumachi; 1983 Aug; 23(4):193-201. PubMed ID: 6420896
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-inflammatory, analgesic and anti-pyretic effects of d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new non-steroidal anti-inflammatory drug, in rats and guinea pigs.
    Kido H; Murakami N; Ito A; Kimura K; Kodera N; Doi T; Naruse T
    Jpn J Pharmacol; 1998 Jan; 76(1):75-86. PubMed ID: 9517407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of gold compounds on lymphocyte transformation and neutrophil chemotaxis--a comparison between sodium aurothiomalate and auranofin].
    Negishi M; Sato H; Sekine F; Ohno I; Kobayashi K; Ohseto Y; Hamai T; Takahashi T
    Ryumachi; 1983 Jun; 23(3):163-7. PubMed ID: 6414094
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
    Coughlan RJ; Richter MB; Panayi GS
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.